pancreatitis and tirzepatide Does Cause Pancreatitis? Evidence Safety Data Tirzepatide and Pancreatitis Risk: Safety

This extended half-life is why semaglutide works as a once-weekly medication rather than requiring daily dosing like some other GLP-1 receptor agonists

The latest GLP-1 drug approved for weight loss, tirzepatide, sold as Zepbound, appears to beat out semaglutide with nearly 19 percent of body weight lost, over 40 pounds (18 kg), with more like five and a half inches (14 cm) off the waist

Allergic reaction: Although these are rare, retatrutide can cause serious hypersensitivity reactions

Kidney problems manifesting as swollen ankles/feet/hands

Discuss side effects and interactions with your doctor or pharmacist